tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market

Editas Medicine (EDIT) Income Statement

Compare
3,395 Followers

Editas Medicine Income Statement

Last quarter (Q3 2024), Editas Medicine's total revenue was $61.00K, a decrease of -98.86% from the same quarter last year. In Q3, Editas Medicine's net income was $-62.14M. See Editas Medicine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 78.12M$ 19.71M$ 25.54M$ 90.73M$ 20.53M
Gross Profit
$ -99.53M$ 13.38M$ 20.49M$ -67.26M$ -76.37M
Operating Expenses
$ 247.30M$ 245.66M$ 218.69M$ 225.57M$ 161.45M
Depreciation and Amortization
$ 6.06M$ 6.34M$ 5.05M$ 3.96M$ 2.83M
EBITDA
$ -163.12M$ -219.61M$ -188.09M$ -130.88M$ -138.09M
Operating Income
$ -169.18M$ -225.95M$ -193.15M$ -134.84M$ -140.92M
Other Income/Expenses
$ 15.96M$ 5.52M$ 644.00K$ 18.86M$ 7.18M
Pretax Income
$ -153.22M$ -220.43M$ -192.50M$ -115.98M$ -133.75M
Net Income
$ -153.22M$ -204.35M$ -185.11M$ -109.41M$ -123.47M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.02$ -2.98$ -2.74$ -1.87$ -2.47
Diluted EPS
$ -2.02$ -2.98$ -2.74$ -1.87$ -2.47
Weighted Average Shares Outstanding
75.97M 68.66M 67.62M 58.61M 49.98M
Weighted Average Shares Outstanding (Diluted)
75.97M 68.66M 67.62M 58.61M 49.98M
Currency in USD

Editas Medicine Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis